Abbott Laboratories stock underperforms Thursday when compared to competitors
The stock's fall snapped a three-day winning streak.
Hosted on MSN3d
Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility
The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...
Abbott Laboratories CEO Robert Ford sells $37.4 million in stock
Chairman and CEO of Abbott Laboratories (NYSE:ABT), recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the Securities and Exchange Commission, Ford ...
Jim Cramer on Abbott Laboratories (ABT): “This Verdict Is an Outrage” – Wall Street Agrees?
His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...
Abbott Laboratories (NYSE:ABT) Upgraded at StockNews.com
StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a ...
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS increase.
This Is What Whales Are Betting On Abbott Laboratories
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $135.0 for Abbott Laboratories over the last 3 months.